Terminology Service for NFDI4Health
T-Cell Activation
Go to external page
http://purl.obolibrary.org/obo/NCIT_C19053
T-Cell Activation involves stimulation of T lymphocytes by receptor interaction with mitogens or cell surface-displayed antigens resulting in biosynthesis of lymphokines, cell proliferation, cell differentiation, and maturation to support immune activity. [ ]
Term info
Label
T-Cell Activation
Synonyms
- T-Cell Activation
Legacy Concept Name
T-Cell_Activation
Preferred Name
T-Cell Activation
Semantic Type
Cell Function
UMLS CUI
C1155065
code
C19053
Term relations
Subclass of:
- Lymphocyte Activation Process
- Biological_Process_Has_Associated_Location some T-Lymphocyte
- Biological_Process_Is_Part_Of_Process some Cell-Mediated Immunity
Related from:
Gene_Plays_Role_In_Process
- TNFSF18 Gene
- ZAP70 Gene
- HLA-DQA1 Gene
- DPP4 Gene
- HAVCR2 Gene
- CD1C Gene
- MICB Gene
- T-Cell Receptor Gene
- LCK Gene
- CD82 Gene
- FCGR2B Gene
- KLRK1 Gene
- PIK3R2 Gene
- HLA-DRA Gene
- CD3E Gene
- CD3D Gene
- TEC Gene
- PIK3R1 Gene
- PTPRC Gene
- CXCL10 Gene
- CCL17 Gene
- PAG1 Gene
- CXCL9 Gene
- LCP2 Gene
- JAK3 Gene
- IL12A Gene
- IL12B Gene
- TNFRSF14 Gene
- HHLA2 Gene
- CAMLG Gene
- TRAT1 Gene
- TNFSF9 Gene
- ICOS Gene
- IL23R Gene
- SH2D1A Gene
- IL23A Gene
- CD1D Gene
- IL16 Gene
- IL15 Gene
- CARD11 Gene
- TNFSF4 Gene
- CD28 Gene
- CD4 Gene
- CD80 Gene
- CD2 Gene
- CD8B Gene
- CD2BP2 Gene
- MICA Gene
- ALCAM Gene
- CD276 Gene
Chemical_Or_Drug_Has_Physiologic_Effect
- Binetrakin
- Adenovirus Expressing Mutant HPV E6/E7
- hVEGF26-104/RFASE Peptide Vaccine
- Alefacept
- Lorukafusp alfa
- Recombinant Vaccinia-Mgp100 Vaccine
- HPV 18 E6:13-21 Peptide
- hTERT-encoding DNA Vaccine INVAC-1
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- MAGE-A3-expressing Adenovirus Type 5 Vaccine
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
- Autologous Cytoplasmic Activated PD-1 CAR T-cells
- Interferon-gamma-expressing Adenovirus Vaccine ASN-002
- Ofatumumab
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D
- UV1 Telomerase Peptide Vaccine
- Neoantigen-based Glioblastoma Vaccine
- Autologous IL-2-expressing B-CLL Vaccine
- Autologous CD40L-expressing B-CLL Vaccine
- Long Peptide Vaccine 7
- 2G-1 TCR Retroviral Vector-Transduced Lymphocytes
- Immunocytokine NHS-IL2-LT
- P53-Synthetic Long Peptides Vaccine
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous PBL
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous TIL
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte
- PR-151 Peptide
- ESO-1 Reactive Autologous Tumor Infiltrating Lymphocyte
- VHL-59: 116-128 Peptide
- VHL-42: 65-76(V74G) Peptide
- gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
- gp100-Reactive Autologous Peripheral Blood Lymphocyte
- SBIL-2 Transduced Autologous Tumor-Infiltrating Lymphocyte
- HPV 16 E6 (18-26) Peptide
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- Fresolimumab
- Liposomal MUC1/PET-lipid A Vaccine ONT-10
- HPV 16 E7:86-93 Peptide Vaccine
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells
- Fowlpox-PSA-TRICOM Vaccine
- Rilimogene Galvacirepvec
- Daromun
- Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201
- Immunocytokine NHS-IL12
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M
- HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
- mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901
- IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
- Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells
- Galinpepimut-S
- Alpha-type-1 Polarized Dendritic Cells
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
- Gag:267-274 Peptide Vaccine
- Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes
- Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300
- WT1 Analog Peptide Vaccine
- Monoclonal Antibody CC49-delta CH2
- Recombinant Vaccinia-TRICOM Vaccine
- Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- Recombinant Fowlpox-TRICOM Vaccine
- Recombinant Fowlpox-B7.1 Vaccine
- Ipilimumab
- Telomerase: 540-548 Peptide Vaccine
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
- Carcinoembryonic Antigen Peptide 1-6D
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- PSA:154-163 Peptide
- PR6V10 (ras-12 Asp) Peptide
- PR-5V10 (ras-12 Val) Peptide
- PR7V10 (ras-12 Ala) Peptide
- PR-54 (ras-13 Asp) Peptide
- PCLUS 6.1-18MN
- PCLUS 3-18MN
- MART-1 Fowlpox Vaccine
- Monoclonal Antibody 95-6-22
- MART-1 Adenovirus Vaccine
- MART-1:26-35(27L) Peptide Vaccine
- MART-1:27-35 Peptide Vaccine
- MART-1 Vaccinia Vaccine
- KLH-Lymphoma Ig Vaccine
- gp100:209-217 Peptide
- gp100:17-25 Peptide
- gp100:280-288 Peptide Vaccine
- gp100-Pulsed Peripheral Blood Mononuclear Cell
- gp100-Fowlpox Vaccine
- gp100:154-162 Peptide Vaccine
- gp100: ES209-217(210M) Peptide
- gp100 and GM-CSF DNA/Gold Vaccine
- Human gp100 Plasmid DNA Vaccine
- ESO-1:157-165(165V) Peptide
- gp100 Adenovirus Vaccine
- Berzofsky Ras/P53 Peptide Vaccine
- VHL16 Peptide
- VHL14 Peptide
- Recombinant Vaccinia-MUC-1 Vaccine
- Tyrosinase:206-214 Peptide